Suchergebnis | Hamburg Open Science

Facetten

18 Einträge gefunden

From gene to clinic: TMA-based clinical validation of molecular markers in prostate cancer.
2010 - Forschungsinformationssystem des UKE
Predictive value of prostate-specific antigen expression in prostate cancer: a tissue microarray study.
2009 - Forschungsinformationssystem des UKE
Prevalence of a tertiary Gleason grade and its impact on adverse histopathologic parameters in a contemporary radical prostatectomy series.
2009 - Forschungsinformationssystem des UKE
Molecular cancer phenotype in normal prostate tissue.
2008 - Forschungsinformationssystem des UKE
Assessment of pathological prostate cancer characteristics in men with favorable biopsy features on predominantly sextant biopsy.
2008 - Forschungsinformationssystem des UKE
Currently used criteria for active surveillance in men with low-risk prostate cancer: an analysis of pathologic features.
2008 - Forschungsinformationssystem des UKE
Microsatellite analysis of allelic imbalance in tumour and blood from patients with prostate cancer.
2008 - Forschungsinformationssystem des UKE
Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men.
2008 - Forschungsinformationssystem des UKE
Biopsies performed at tertiary care centers are superior to referral biopsies in predicting pathologic Gleason sum.
2008 - Forschungsinformationssystem des UKE
Development and split-sample validation of a nomogram predicting the probability of seminal vesicle invasion at radical prostatectomy.
2007 - Forschungsinformationssystem des UKE
Zonal origin of localized prostate cancer does not affect the rate of biochemical recurrence after radical prostatectomy.
2007 - Forschungsinformationssystem des UKE
Development and external validation of an extended 10-core biopsy nomogram.
2007 - Forschungsinformationssystem des UKE
Body mass index does not improve the ability to predict biochemical recurrence after radical prostatectomy.
2007 - Forschungsinformationssystem des UKE
Tumour volume and high grade tumour volume are the best predictors of pathologic stage and biochemical recurrence after radical prostatectomy.
2007 - Forschungsinformationssystem des UKE
Effect of autologous blood transfusion on the rate of biochemical recurrence after radical prostatectomy.
2007 - Forschungsinformationssystem des UKE
Detection of tumor-specific DNA in blood and bone marrow plasma from patients with prostate cancer.
2007 - Forschungsinformationssystem des UKE
Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European men.
2007 - Forschungsinformationssystem des UKE
Health-insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancer.
2007 - Forschungsinformationssystem des UKE

Aktive Facetten

Facetten

Zugriff

Einrichtung

Medientyp

Karte

Erscheinungsjahr

Autor/in

Sprache

From gene to clinic: TMA-based clinical validation of molecular markers in prostate cancer.

Predictive value of prostate-specific antigen expression in prostate cancer: a tissue microarray study.

Prevalence of a tertiary Gleason grade and its impact on adverse histopathologic parameters in a contemporary radical prostatectomy series.

Molecular cancer phenotype in normal prostate tissue.

Assessment of pathological prostate cancer characteristics in men with favorable biopsy features on predominantly sextant biopsy.

Currently used criteria for active surveillance in men with low-risk prostate cancer: an analysis of pathologic features.

Microsatellite analysis of allelic imbalance in tumour and blood from patients with prostate cancer.

Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men.

Biopsies performed at tertiary care centers are superior to referral biopsies in predicting pathologic Gleason sum.

Development and split-sample validation of a nomogram predicting the probability of seminal vesicle invasion at radical prostatectomy.

Zonal origin of localized prostate cancer does not affect the rate of biochemical recurrence after radical prostatectomy.

Development and external validation of an extended 10-core biopsy nomogram.

Body mass index does not improve the ability to predict biochemical recurrence after radical prostatectomy.

Tumour volume and high grade tumour volume are the best predictors of pathologic stage and biochemical recurrence after radical prostatectomy.

Effect of autologous blood transfusion on the rate of biochemical recurrence after radical prostatectomy.

Detection of tumor-specific DNA in blood and bone marrow plasma from patients with prostate cancer.

Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European men.

Health-insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancer.